Company / R&D Expense
Bone Biologics Corp R&D Expense History
FY2017-FY2020 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D Expense
$1.1M
FY2020
5-year range
$104.5K / $7.0M
FY2017-FY2020
Trend
+948.1%
vs FY2019
Sector context
Sector data unavailable
Latest sector comparison
What the data says
R&D Expense changed +948% YoY in FY2020, a notable deviation from the 3-year average annual change of +259%.
Based on SEC 10-K filings.
$1M in FY2020 with a 3-year CAGR of -46.1%.
Declined from $1M to $1M over the past 2 years.
R&D Expense over time
Growth rates
- 3-Year CAGR
- -46.1%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- 3-year CAGR of -46.1%, indicating a declining trend.
- In FY2020, r&d expense increased 948.1% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2020 | $1.1M | +948.1% |
| FY2019 | $104.5K | -92.6% |
| FY2018 | $1.4M | -79.8% |
| FY2017 | $7.0M | - |
As of FY2020 · SEC 10-K · Updated Jun 28, 2026